When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
VXRT - Vaxart +8% on completing dosing in norovirus vaccine phase 1b trial
Vaxart Inc.
Vaxart (NASDAQ:VXRT) completes dosing of the lead-in cohort in the Phase 1b bivalent norovirus vaccine clinical trial with its oral norovirus GII.4 vaccine.
More news on: Vaxart, Inc., Healthcare stocks news, Stocks on the move,